GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » DWS Municipal Income Trust (NYSE:KTF) » Definitions » Research & Development

DWS Municipalome Trust (DWS Municipalome Trust) Research & Development : $0.00 Mil (TTM As of Nov. 2023)


View and export this data going back to . Start your Free Trial

What is DWS Municipalome Trust Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. DWS Municipalome Trust's Research & Development for the six months ended in Nov. 2023 was $0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Nov. 2023 was $0.00 Mil.

DWS Municipalome Trust Research & Development Historical Data

The historical data trend for DWS Municipalome Trust's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DWS Municipalome Trust Research & Development Chart

DWS Municipalome Trust Annual Data
Trend Nov17 Nov18 Nov19 Nov20 Nov21 Nov22 Nov23
Research & Development
Get a 7-Day Free Trial - - - - -

DWS Municipalome Trust Semi-Annual Data
Nov17 May18 Nov18 May19 Nov19 May20 Nov20 May21 Nov21 May22 Nov22 May23 Nov23
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

DWS Municipalome Trust Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Nov. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DWS Municipalome Trust  (NYSE:KTF) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

DWS Municipalome Trust Research & Development Related Terms

Thank you for viewing the detailed overview of DWS Municipalome Trust's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

DWS Municipalome Trust (DWS Municipalome Trust) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » DWS Municipal Income Trust (NYSE:KTF) » Definitions » Research & Development
Comparable Companies
MIN XFLT ACP PMO FINS BFZ NAN HQL HPF HIX BLK BX OSTO:INVE A TSX:BN KKR APO BK AMP XSWX:PGHN LSE:III
Traded in Other Exchanges
N/A
Address
875 Third Avenue, New York, NY, USA, 10022-6225
Website
https://www.dws.com
DWS Municipal Income Trust is a closed-end, diversified investment management company. The investment objective is to provide high current income exempt from federal income tax by investing in a diversified portfolio of investment-grade tax-exempt securities. Its products include ETFs, Mutual Funds, Closed-End-Funds, Money Market Funds, and others.
Executives
Jpmorgan Chase Bank, National Association 10 percent owner 1111 POLARIS PARKWAY, COLUMBUS OH 43240
Mary S Daugherty director C/O ANJIE LAROCCA, DWS, 875 THIRD AVENUE, NEW YORK NY 10022
George Catrambone other: Director of Investment Adviser C/O ANJIE LAROCCA, DWS, 875 THIRD AVENUE, NEW YORK NY 10022
Richard J Herring director 345 PARK AVENUE, NEW YORK NY 10154
Chad Perry director C/O TANGER FACTORY OUTLET CENTERS, INC., 3200 NORTHLINE AVENUE, SUITE 360, GREENSBORO NC 27408
Catherine Schrand director C/O ANJIE LAROCCA, DWS, 875 THIRD AVENUE, NEW YORK NY 10022
Christian Rijs officer: AML Compliance Officer C/O DWS, 875 THIRD AVENUE, NEW YORK NY 10022
Chad Farrington other: Portfolio Manager C/O ANJIE LAROCCA, DWS, 345 PARK AVENUE, NEW YORK NY 10154
Helen Delman other: Section 16 C/O DWS, 875 THIRD AVENUE, NEW YORK NY 10022
Jpmorgan Chase Bank, N.a. 10 percent owner 1111 POLARIS PARKWAY, COLUMBUS OH 43240
John W Ballantine director C/O OAK BROOK BANK, 1400 SIXTEENTH ST, OAK BROOK IL 60523
Keith R Fox director 85 MERRIMAC STREET, BOSTON MA 02114
Ciara L. Crawford officer: Assistant Secretary C/O ANJIE LAROCCA, DWS, 345 PARK AVENUE, NEW YORK NY 11752
Peter Aloisi other: Portfolio Manager C/O ANJIE LAROCCA, 345 PARK AVENUE, NEW YORK NY 10154
William N Searcy director 345 PARK AVENUE, NEW YORK NY 10154